About This Event

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Kent Hawryluk, President & Chief Executive Officer, rings the Opening Bell.